(Q44673368)

5 December 2017

Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep (English)

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

5 January 2023

1 reference

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

5 January 2023

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

5 January 2023

author name string

A. E. Tufenkji

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3400265

5 January 2023

M. Alvinerie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3400265

5 January 2023

T. Pineau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3400265

5 January 2023

C. Boulard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3400265

5 January 2023

P. Galtier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3400265

5 January 2023

language of work or name

English

0 references

publication date

1 April 1988

1 reference

full work available at URL

5 December 2017

http://www.tandfonline.com/doi/pdf/10.3109/00498258809041671

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

5 January 2023

1 reference

5 December 2017

18

1 reference

5 December 2017

4

1 reference

5 December 2017

357-364

1 reference

Biochemical indicators of liver injury in calves with experimental fascioliasis

5 December 2017

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Antipyrine kinetics in liver disease and liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Differential induction of antipyrine metabolism by rifampicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498258809041671

Interindividual variations in drug disposition. Clinical implications and methods of investigation

21 January 2018

5

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Studies on rat liver cytochrome P-450s involved in the metabolism of antipyrine: phenobarbital- and 3-methylcholanthrene-inducible isozymes possessing 4-hydroxylase activity

5 January 2023

6

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes

5 January 2023

9

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Characterization of the microsomal cytochrome P-450 species inhibited in rat liver in the course of fascioliasis

5 January 2023

10

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Drug Metabolism and Disposition

5 January 2023

11

14

137

Galtier P.

1986

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Fasciola hepatica: plasma ascorbic acid, plasma iron and iron-binding capacity in experimentally infected sheep

5 January 2023

12

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man

5 January 2023

15

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

High‐Pressure Liquid Chromatographic Analysis of Antipyrine in Small Plasma Samples

5 January 2023

17

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays

5 January 2023

18

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Bile flow, bile salt secretion and the excretion of iron, copper, zinc and manganese in the bile of calves infected with Fasciola hepatica

5 January 2023

20

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis

5 January 2023

22

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

Pharmacokinetics of sulphobromophthalein, lidocaine and indocyanine green in the course of subclinical fascioliasis in sheep.

5 January 2023

24

1 reference

https://api.crossref.org/works/10.3109/00498258809041671

5 January 2023

Identifiers

1 reference

5 December 2017

1 reference